These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36443582)

  • 21. Causal mediation effects in single case experimental designs.
    Valente MJ; Rijnhart JJM; Miočević M
    Psychol Methods; 2023 Apr; 28(2):488-506. PubMed ID: 35549318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncertainties beyond statistics in Monte Carlo simulations.
    Hughes HG
    Radiat Prot Dosimetry; 2007; 126(1-4):45-51. PubMed ID: 17766264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Power and sample size calculations for comparison of two regression lines with heterogeneous variances.
    Shieh G
    PLoS One; 2018; 13(12):e0207745. PubMed ID: 30557387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing Statistical Power in Mediation Models Without Increasing Sample Size.
    Fritz MS; Cox MG; MacKinnon DP
    Eval Health Prof; 2015 Sep; 38(3):343-66. PubMed ID: 24346658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A gentle tutorial on power simulations in suicide research: Worked examples in R.
    Cero I
    Suicide Life Threat Behav; 2021 Feb; 51(1):162-174. PubMed ID: 33624874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional Direction Dependence Analysis: Evaluating the Causal Direction of Effects in Linear Models with Interaction Terms.
    Li X; Wiedermann W
    Multivariate Behav Res; 2020; 55(5):786-810. PubMed ID: 31713434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect Effects in Sequential Mediation Models: Evaluating Methods for Hypothesis Testing and Confidence Interval Formation.
    Tofighi D; Kelley K
    Multivariate Behav Res; 2020; 55(2):188-210. PubMed ID: 31179751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causal moderated mediation analysis: Methods and software.
    Qin X; Wang L
    Behav Res Methods; 2024 Mar; 56(3):1314-1334. PubMed ID: 37845423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical power calculations for structural equation modeling: A tutorial and Shiny app.
    Jak S; Jorgensen TD; Verdam MGE; Oort FJ; Elffers L
    Behav Res Methods; 2021 Aug; 53(4):1385-1406. PubMed ID: 33140375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothesis test of mediation effect in causal mediation model with high-dimensional continuous mediators.
    Huang YT; Pan WC
    Biometrics; 2016 Jun; 72(2):402-13. PubMed ID: 26414245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A default Bayesian hypothesis test for mediation.
    Nuijten MB; Wetzels R; Matzke D; Dolan CV; Wagenmakers EJ
    Behav Res Methods; 2015 Mar; 47(1):85-97. PubMed ID: 24903686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An example of complex modelling in dentistry using Markov chain Monte Carlo (MCMC) simulation.
    Helfenstein U; Menghini G; Steiner M; Murati F
    Community Dent Health; 2002 Sep; 19(3):152-60. PubMed ID: 12269461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond total treatment effects in randomised controlled trials: Baseline measurement of intermediate outcomes needed to reduce confounding in mediation investigations.
    Landau S; Emsley R; Dunn G
    Clin Trials; 2018 Jun; 15(3):247-256. PubMed ID: 29552919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: part I. Model prediction using Monte Carlo simulation.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Apr; 99(4):2114-22. PubMed ID: 19902528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-computation demonstration in causal mediation analysis.
    Wang A; Arah OA
    Eur J Epidemiol; 2015 Oct; 30(10):1119-27. PubMed ID: 26537707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of adjoint Monte Carlo to accelerate simulations of mono-directional beams in treatment planning for boron neutron capture therapy.
    Nievaart VA; Légràdy D; Moss RL; Kloosterman JL; van der Hagen TH; van Dam H
    Med Phys; 2007 Apr; 34(4):1321-35. PubMed ID: 17500463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.
    Austin PC; Grootendorst P; Anderson GM
    Stat Med; 2007 Feb; 26(4):734-53. PubMed ID: 16708349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A note on power and sample size calculations for the Kruskal-Wallis test for ordered categorical data.
    Fan C; Zhang D
    J Biopharm Stat; 2012; 22(6):1162-73. PubMed ID: 23075015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power and sample size calculations for exact conditional tests with ordered categorical data.
    Hilton JF; Mehta CR
    Biometrics; 1993 Jun; 49(2):609-16. PubMed ID: 8369392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: Part II. Error propagation during product performance modeling.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Aug; 99(8):3572-8. PubMed ID: 20564385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.